Schwab Charles Investment Management Inc. lessened its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 7.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 84,857 shares of the company’s stock after selling 7,204 shares during the period. Schwab Charles Investment Management Inc. owned about 0.35% of USANA Health Sciences worth $4,897,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in USNA. BNP Paribas Arbitrage SA lifted its stake in USANA Health Sciences by 13.1% during the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after purchasing an additional 245 shares during the period. Victory Capital Management Inc. lifted its stake in USANA Health Sciences by 17.6% during the second quarter. Victory Capital Management Inc. now owns 2,490 shares of the company’s stock worth $160,000 after purchasing an additional 373 shares during the period. SG Americas Securities LLC bought a new position in USANA Health Sciences during the second quarter worth about $162,000. Legal & General Group Plc lifted its stake in USANA Health Sciences by 7.6% during the second quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after purchasing an additional 284 shares during the period. Finally, Trust Co. of Vermont lifted its stake in USANA Health Sciences by 482.7% during the third quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock worth $272,000 after purchasing an additional 3,900 shares during the period. Institutional investors and hedge funds own 44.35% of the company’s stock.
USANA Health Sciences, Inc. (NYSE USNA) traded up $0.30 during trading hours on Thursday, hitting $74.95. 88,877 shares of the stock were exchanged, compared to its average volume of 75,181. The company has a market capitalization of $1,810.24, a PE ratio of 20.65 and a beta of 1.06. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $76.80.
In related news, major shareholder Global Ltd Gull sold 7,289 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $66.01, for a total value of $481,146.89. Following the completion of the sale, the insider now owns 11,996,192 shares of the company’s stock, valued at $791,868,633.92. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Myron W. Wentz sold 164,916 shares of the firm’s stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $66.40, for a total transaction of $10,950,422.40. The disclosure for this sale can be found here. In the last three months, insiders sold 386,120 shares of company stock valued at $25,580,462. 53.20% of the stock is currently owned by company insiders.
USNA has been the subject of a number of analyst reports. Pivotal Research raised their price target on shares of USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, October 25th. BidaskClub cut shares of USANA Health Sciences from a “hold” rating to a “sell” rating in a research note on Thursday, November 2nd. Finally, Sidoti cut shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th.
TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/01/schwab-charles-investment-management-inc-sells-7204-shares-of-usana-health-sciences-inc-usna.html.
USANA Health Sciences Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.